{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:07:56Z","timestamp":1760188076465},"reference-count":37,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1007\/s10227-001-0040-y","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T13:47:51Z","timestamp":1033912071000},"page":"109-116","source":"Crossref","is-referenced-by-count":5,"title":["Transformation in mycosis fungoides: The role of methotrexate"],"prefix":"10.1177","volume":"6","author":[{"given":"Jasmin","family":"Abd-el-Baki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-France","family":"Demierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine M.","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"602000109_CR1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1524-4725.1980.tb00880.x","volume":"6","author":"RL. Edelson","year":"1980","unstructured":"Edelson RL. Cutaneous T-cell lymphoma. J Dermatol Surg Oncol 1980; 6:358\u2013368.","journal-title":"J Dermatol Surg Oncol"},{"key":"602000109_CR2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1200\/JCO.1987.5.2.208","volume":"5","author":"E Dmitrovsky","year":"1987","unstructured":"Dmitrovsky E, Matthews MJ, Bunn PA, et al. Cytologic transformation in cutaneous T-cell lymphoma: A clinicpathologic entity associated with poor prognosis. J Clin Oncol 1987; 5:208\u2013215.","journal-title":"J Clin Oncol"},{"key":"602000109_CR3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-199206000-00002","volume":"16","author":"L Cerroni","year":"1992","unstructured":"Cerroni L, Rieger E, Hodl S, et al. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol 1992; 16:543\u2013552.","journal-title":"Am J Surg Pathol"},{"key":"602000109_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1097-0142(19810101)47:1<119::AID-CNCR2820470120>3.0.CO;2-F","volume":"47","author":"EC Vonderheid","year":"1981","unstructured":"Vonderheid EC, Tarn DW, Johnson WC, et al. Prognostic significance of cytomorphology in the cutaneous T-cell lymphomas. Cancer 1981; 47:119\u2013125.","journal-title":"Cancer"},{"key":"602000109_CR5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1523-1747.ep12365416","volume":"101","author":"GS Wood","year":"1993","unstructured":"Wood GS, Bahler DW, Hoppe RT, et al. Transformation of mycosis fungoides: T-cell receptor \u03b2 gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma. J Invest Dermatol 1993; 101: 296\u2013300.","journal-title":"J Invest Dermatol"},{"key":"602000109_CR6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0190-9622(96)80062-4","volume":"34","author":"HS Zackheim","year":"1996","unstructured":"Zackheim HS, Kashani-Sabet M, Hwang ST. Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: Results in twenty-nine patients. J Am Acad Dermatol 1996; 34:626\u2013631.","journal-title":"J Am Acad Dermatol"},{"key":"602000109_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.1780390223","volume":"39","author":"TR Bachman","year":"1996","unstructured":"Bachman TR, Sawitzke AD, Perkins SL, et al. Methotrexateassociated lymphoma in patients with rheumatoid arthritis: Report of two cases. Arthritis Rheum 1996; 39:325\u2013329.","journal-title":"Arthritis Rheum"},{"key":"602000109_CR8","first-page":"1462","volume":"19","author":"SF Kingsmore","year":"1992","unstructured":"Kingsmore SF, Hall BD, Alien NB, et al. Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review. J Rheumatol 1992;19:1462\u20131465.","journal-title":"J Rheumatol"},{"issue":"Suppl 1A","key":"602000109_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9343(85)90243-8","volume":"78","author":"CW Castor","year":"1985","unstructured":"Castor CW, Bull FE. Review of United States data on neoplasms in rheumatoid arthritis. Am J Med 1985; 78(Suppl 1A):33\u201338.","journal-title":"Am J Med"},{"key":"602000109_CR10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/ard.50.5.275","volume":"50","author":"P Porter","year":"1991","unstructured":"Porter P, Madhok R, Capell H. Non-Hodgkin\u2019s lymphoma in rheumatoid arthritis. Ann Rheum Dis 1991; 50:275\u2013276.","journal-title":"Ann Rheum Dis"},{"key":"602000109_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-120-1-199401010-00006","volume":"120","author":"G Gridley","year":"1994","unstructured":"Gridley G, Klippel J, Hoover R, et al. Incidence of cancer among men with the Felty syndrome. Ann Intern Med 1994; 120:35\u201339.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1A","key":"602000109_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0002-9343(85)90241-4","volume":"78","author":"DPM Symmons","year":"1985","unstructured":"Symmons DPM. Neoplasms of the immune system in rheumatoid arthritis. Am J Med 1985; 78 (Suppl 1A):22\u201328.","journal-title":"Am J Med"},{"key":"602000109_CR13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","volume":"89","author":"SS Kassan","year":"1978","unstructured":"Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lvmphoma in sicca syndrome. Ann Intern Med 1978; 89:888\u20138921","journal-title":"Ann Intern Med"},{"key":"602000109_CR14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","volume":"328","author":"OW Kamel","year":"1993","unstructured":"Kamel OW, van de Rijn M, Weiss LM, et al. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993; 328:1317\u20131321.","journal-title":"N Engl J Med"},{"key":"602000109_CR15","first-page":"1174","volume":"22","author":"F Liote","year":"1995","unstructured":"Liote F, Pertuiset E, Cochand-Priollet B, et al. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis: Role of Epstein-Barr virus infection. J Rheumatol 1995; 22:1174\u20131178.","journal-title":"J Rheumatol"},{"key":"602000109_CR16","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/1097-0142(197410)34:4<1198::AID-CNCR2820340431>3.0.CO;2-E","volume":"34","author":"H Rappaport","year":"1974","unstructured":"Rappaport H, Thomas LB: Mycosis fungoides: The pathology of extracutaneous involvement. Cancer 1974; 34:1198\u20131229.","journal-title":"Cancer"},{"key":"602000109_CR17","first-page":"725","volume":"63","author":"PA Jr Bunn","year":"1979","unstructured":"Bunn PA Jr, Lamberg SI. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer 1979; 63:725\u2013728.","journal-title":"Cancer"},{"key":"602000109_CR18","first-page":"265","volume":"132","author":"KE Salhany","year":"1988","unstructured":"Salhany KE, Cousar JB, Greer JP, et al. Transformation of cutaneous T-cell lymphoma to large-cell lymphoma: A clinicopathologic and immunologic study. Am J Pathol 1988; 132:265\u2013277.","journal-title":"Am J Pathol"},{"key":"602000109_CR19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1182\/blood.V59.5.913.913","volume":"59","author":"GS Wood","year":"1982","unstructured":"Wood GS, Warnke R. The immunophenotyping of bone marrow biopsies and aspirates: Frozen section techniques. Blood 1982; 59:913\u2013922.","journal-title":"Blood"},{"key":"602000109_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.1711680311","volume":"168","author":"P Kanavaros","year":"1992","unstructured":"Kanavaros P, Jiva NM, de Bruin PC, et al. High incidence of EBV genome in CD-30 positive non-Hodgkin\u2019s lymphoma. J Pathol 1992; 168:307\u2013315.","journal-title":"J Pathol"},{"key":"602000109_CR21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/1523-1747.ep12389114","volume":"103","author":"GS Wood","year":"1994","unstructured":"Wood GS, Tung RM, Haeffner AC, et al. Detection of clonal T-cell receptor \u03b3 gene rearrangements in early mycosis fungoides\/ Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR\/DGGE). J Invest Dermatol 1994; 103:34\u201341.","journal-title":"J Invest Dermatol"},{"key":"602000109_CR22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0560.1999.tb01825.x","volume":"26","author":"WK Anderson","year":"1999","unstructured":"Anderson WK, Li N, Bhawan J. Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR\/DGGE) based detection of clonal T-cell receptor \u03b3 gene rearrangements on paraffin-embedded cutaneous biopsies in cutaneous T-cell lymphoproliferative disorders. J Cutan Pathol 1999; 26:176\u2013182.","journal-title":"J Cutan Pathol"},{"key":"602000109_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12312548","volume":"105","author":"GS Wood","year":"1995","unstructured":"Wood GS, Grooks CF, Uluer AZ. Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin. J Invest Dermatol 1995; 105:51\u201355.","journal-title":"J Invest Dermatol"},{"key":"602000109_CR24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457.","journal-title":"J Am Stat Assoc"},{"key":"602000109_CR25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0190-9622(93)70140-O","volume":"28","author":"R Willemze","year":"1993","unstructured":"Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-l)-positive lymphoproliferative disorders: A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol1993; 28:973\u2013980.","journal-title":"J Am Acad Dermatol"},{"key":"602000109_CR26","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","volume":"92","author":"E Diamandidou","year":"1998","unstructured":"Diamandidou E, Colome-Grimmer M, Fayad L, et al. Transformation of mycosis fungoides\/Sezary syndrome: Clinical characteristics and prognosis. Blood 1998; 92:1150\u20131159.","journal-title":"Blood"},{"key":"602000109_CR27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","volume":"40","author":"HS Zackheim","year":"1999","unstructured":"Zackheim HS, Amin S, Kashani-Sabet M, et al. Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients. J Am Acad Dermatol 1999; 40:418\u2013425.","journal-title":"J Am Acad Dermatol"},{"key":"602000109_CR28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","volume":"132","author":"YH Kim","year":"1996","unstructured":"Kim YH, Jensen RA, Watanabe GL, et al. Clinical stage 1A (limited patch and plaque) mycosis fungoides: A long-term outcome analysis. Arch Dermatol 1996; 132:1309\u20131313.","journal-title":"Arch Dermatol"},{"key":"602000109_CR29","first-page":"26","volume":"135","author":"YH Kim","year":"1999","unstructured":"Kim YH, Chow S, Varghese A, et al. Clinical characteristics and long-term outcome of patients with generalized patch and\/or plaque (T2) mycosis fungoides. Arch Dermatol 1999; 135:26\u201332.","journal-title":"Arch Dermatol"},{"key":"602000109_CR30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0923-1811(93)90001-6","volume":"6","author":"M Volkenandt","year":"1993","unstructured":"Volkenandt M, Bertino JR, Shenoy V, et al. Molecular evidence for a clonal relationship between lymphomatoid papulosis and Ki-1 positive large cell anaplastic lymphoma. J Dermatol Sci 1993; 6:121\u2013126.","journal-title":"J Dermatol Sci"},{"key":"602000109_CR31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1346-8138.1995.tb03913.x","volume":"22","author":"M Amagai","year":"1995","unstructured":"Amagai M, Kawakubo Y, Tsuyuki A, et al. Lymphomatoid papulosis followed by Ki-1 positive anaplastic large cell lymphoma: Proliferation of a common T-cell clone. J Dermatol 1995; 22:743\u2013746.","journal-title":"J Dermatol"},{"key":"602000109_CR32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2133.1996.tb03621.x","volume":"135","author":"R Viraben","year":"1996","unstructured":"Viraben R, Brousse P, Lamant L. Reversible cutaneous lymphoma occurring during methotrexate therapy. Br J Dermatol 1996; 135:116\u2013118.","journal-title":"Br J Dermatol"},{"key":"602000109_CR33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1529-0131(199801)41:1<48::AID-ART7>3.0.CO;2-K","volume":"41","author":"A Constantin","year":"1998","unstructured":"Constantin A, Loubet-Lescoulie P, Lambert N, et al. Anti-inflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: Evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse polymerase chain reaction. Arthritis Rheum 1998; 41:48\u201357.","journal-title":"Arthritis Rheum"},{"key":"602000109_CR34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/1523-1747.ep12398454","volume":"103","author":"BR Vowels","year":"1994","unstructured":"Vowels BR, Lessin SR, Cassin M, et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 1994; 103:619\u2013673.","journal-title":"J Invest Dermatol"},{"key":"602000109_CR35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1097-0142(19820901)50:5<869::AID-CNCR2820500511>3.0.CO;2-V","volume":"50","author":"RS Stern","year":"1982","unstructured":"Stern RS, Zierler S, Parrish JA. Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy. Cancer 1982; 50:869\u2013872.","journal-title":"Cancer"},{"key":"602000109_CR36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jama.1975.03250040013017","volume":"232","author":"PL Bailin","year":"1975","unstructured":"Bailin PL, Tindall JP, Roenigk HH, et al. Is methotrexate therapy for psoriasis carcinogenic? JAMA 1975; 232:359\u2013362.","journal-title":"JAMA"},{"key":"602000109_CR37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM198303033080901","volume":"308","author":"GJ Rustin","year":"1983","unstructured":"Rustin GJ, Rustin F, Rent J, et al. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors. N Engl J Med 1983; 308:473\u2013476.","journal-title":"N Engl J Med"}],"container-title":["Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1007\/s10227-001-0040-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:31:48Z","timestamp":1583415108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10227-001-0040-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["602000109"],"URL":"https:\/\/doi.org\/10.1007\/s10227-001-0040-y","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}